ReviewWorld journal of hepatology2017
Role of surgical resection for non-colorectal non-neuroendocrine liver metastases.
Review in World journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 40 citations in OpenAlex.
- Managing dual primary liver metastases from breast and colorectal cancers.Clinical journal of gastroenterology · 2026Article
- [Non-colorectal liver metastases-Indications and treatment approach].Chirurgie (Heidelberg, Germany) · 2026Review
- Article
- Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.Molecular cancer · 2024Review
- Metastasectomy of a solitary liver tumor from prostate cancer after radical prostatectomy.IJU case reports · 2023Article
- Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.Clinical & experimental metastasis · 2022Article
- Hepatectomy for liver metastases from cervical cancer with portal vein tumor thrombosis: a case report.Clinical journal of gastroenterology · 2022Article
- Surgery for Liver Metastasis of Non-Colorectal and Non-Neuroendocrine Tumors.Journal of clinical medicine · 2022Article
- Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach.World journal of hepatology · 2021Review
- Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.Journal of gastrointestinal oncology · 2021Article
- Long-term survival after pancreatic metastasis resection from breast cancer: a systematic literature review.Surgical case reports · 2021Article
- The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.World journal of surgical oncology · 2020Article
- Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer.Journal of gynecologic surgery · 2020Article
- Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020Article
- Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.World journal of surgical oncology · 2019Article
- Liver resection for non-colorectal metastases.European surgery : ACA : Acta chirurgica Austriaca · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is widely accepted that the indications for hepatectomy in colorectal cancer liver metastases and liver metastases of neuro-endocrine tumors result in relatively better prognoses, whereas, the indications and prognoses of hepatectomy for non-colorectal non-neuroendocrine liver metastases (NCNNLM) remain controversial owing to the limited number of cases and the heterogeneity of the primary diseases. There have been many publications on NCNNLM; however, its background heterogeneity makes it difficult to reach a specific conclusion. This heterogeneous disease group should be discussed in the order from its general to specific aspect. The present review paper describes the general prognosis and risk factors associated with NCNNLM while specifically focusing on the liver metastases of each primary disease. A multidisciplinary approach that takes into consideration appropriate timing for hepatectomy combined with chemotherapy may prolong survival and/or contribute to the improvement of the quality of life while giving respite from systemic chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.